Vascular Dementia clinical trials at UCSF
1 research study open to eligible people
Showing trials for
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
open to eligible people ages 18 years and up
This is an observational study to better understand the risk factors and progression of CADASIL, a leading cause of vascular cognitive impairment and dementia (VCID). 575 participants will be enrolled and can expect to be on study for up to 5 years.
San Francisco 5391959, California 5332921 and other locations
Our lead scientists for Vascular Dementia research studies include Michael D Geschwind, MD.